吴昊泽qq】【圣邦注塑机机筒批发】【徐莹门】【黑暗之光龙臂】【兖矿一中贴吧】【韩国中断扩音喊话】【虫血沸腾2虫仙争霸】【徐大荣自曝已婚】【失落军团的封印书典】【游龙戏凤快播】【前妻乖乖跟我回家】【酒驾冲进大运河】【霍政谚女友】【曲京远】【九阴真经斩虎刀鞘】【塞萨尔老婆】【一个色夫导航】【两天一夜131006】【盟军夺宝队百度影音】【张学津去世】【千里达 木】【伟哥 鸡年嘉年华专场】【傲世九重天墨坛文学】【男子意外获藏宝图 挖出大宝贝】【女老板穿旧衣服的视频】【正者无敌谁是山羊】【爱在那一天票房】【qq仙灵大幸运星怎么获得】【鹦鹉来过吴江水】【明星豪门恋】【情陷高处】【夏洛特烦恼 ed2k】【濠江岁月国语】【温舒网】【将夜 快眼看书】【双胞胎伊莲微博

捕鱼游戏厅

您好,欢迎光临安诺伦(捕鱼游戏厅手机版)生物科技商城!
全国服务热线:400-965-8633
关注我们
  • 会员中心
  • 会员中心
    询价列表
    0

    最新加入的商品

    0 件商品 合计:¥ 0
  • 会员中心
    购物车

    最新加入的商品

    件商品 合计:¥ 0

全部产品分类

优势品牌
当前位置:首页 > Monoclonal Antibody Center

Monoclonal Antibody Center


华盛顿州立大学单克隆抗体中心(Monoclonal Antibody Center)是WSU的服务中心。它提供了一系列与WSU关联的研究人员和临床医生的单克隆抗体的生产和特性相关的服务。该中心的研究常用于临床问题。临床研究是对具有天然疾病的动物的有效性进行评估的新药物或手术的测试。在某些情况下,将新药或手术的有效性与目前可用的治疗方法进行比较。VCS的学院还与大学其他部门的教师合作。


In the mid 70s, a group of investigators demonstrated in mice that it is possible to immortalize B  lymphocytes producing single monospecific antibodies (mAbs) by fusing B lymphocytes to tissue culture adapted myeloma (malignant form of an antibody producing cell) cells. The hybrid cells (hybridomas) were stable and could be maintained in culture indefinitely or preserved in liquid nitrogen for later use. These findings represented a major breakthrough in the way antibody reagents could be developed for basic and biomedical research. Mice could be immunized with antigens of interest and then used as a source of B lymphocytes to produce mAbs of known specificity. The spleen was shown to be the best source of B lymphocytes for making hybridomas. Hybridomas producing the desired mAbs could be identified by examining culture medium from primary cultures of fused cells. In subsequent investigations, myeloma fusion partners were developed that could only grow in selective growth medium if fused to a B lymphocyte, eliminating the problem of distinguishing hybridomas from cells that had not fused with a B lymphocyte. Myeloma fusion partners were later identified that could no longer produce their own antibody but could produce antibody derived from the B lymphocyte. These advances simplified and improved the methodology for producing mAbs.

Research universities, research institutes and industry established core facilities to exploit mAb technology to develop mAbs for use as analytical tools in the biological and biomedical sciences, in the characterization of the immune system, study the mechanisms by which pathogens cause disease, develop improved diagnostic assays, and identify antigens from pathogens that can be used in subunit vaccines. Because of our research needs, we started developing mAbs for use in food and companion animal research and diagnostic medicine in 1979. To encourage other investigators to use mAb technology, we sponsored the first international symposium and workshop ‘Impact of Monoclonal Antibody Technology on Animal and Plant Agricultural Research’ in June of 1982. We also participated in a workshop sponsored by the National Research Council of the National Academy of Science on ‘Priorities in Biotechnology Research for International Development held in July of 1982, a symposium sponsored by the USDA ‘Hybridoma Technology in Agricultural and Veterinary Research’ held in Oct. of 1983 and an international conference sponsored by the International Laboratory for Research on Animal Diseases ‘The Ruminant Immune System In Health and Disease’ held in Kenya Africa in September 1983. In 1984, we co-sponsored a meeting with Australia ‘Characterization of the Bovine Immune System and the Genes Regulating Expression of Immunity with Particular Reference to their Role in Disease Resistance’ held in Honolulu, Hawaii. During this period of time, we developed some of the first sets of mAbs for use in the study of the immune system in food and companion animals. We also participated in all the international workshops to characterize the first sets of mAbs.


sitemap.xml